Literature DB >> 9106532

Molecular characterization of patients with 18q23 deletions.

G Strathdee1, R Sutherland, J J Jonsson, R Sataloff, M Kohonen-Corish, D Grady, J Overhauser.   

Abstract

The 18q- syndrome is a deletion syndrome that is characterized by mental retardation, hearing loss, midfacial hypoplasia, growth deficiency, and limb anomalies. Most patients with this syndrome have deletions from 18q21-qter. We report on three patients with deletions of 18q23. A mother and daughter with identical deletions of 18q23 have many of the typical features of the 18q- syndrome, including midfacial hypoplasia and hearing loss. In contrast, the third patient has few of the symptoms of the 18q- syndrome. A contig of the 18q23 region was generated to aid in the mapping of the breakpoints. FISH was used to map both breakpoints to the same YAC clone. Furthermore, somatic-cell hybrids from the daughter and the third patient were isolated. The mapping results of sequence-tagged sites relative to the two breakpoints were identical, suggesting that the two deletion breakpoints map very close to one another. The analyses of these patients demonstrate that the critical region for the 18q- syndrome maps to 18q23 but that a deletion of 18q23 does not always lead to the clinical features associated with the syndrome. These patients demonstrate the wide phenotypic variability associated with deletions of 18q.

Entities:  

Mesh:

Year:  1997        PMID: 9106532      PMCID: PMC1712465     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  [PARTIAL DELETION OF THE LONG ARMS OF THE CHROMOSOME 18].

Authors:  J DE GROUCHY; P ROYER; C SALMON; M LAMY
Journal:  Pathol Biol       Date:  1964-05

2.  Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors.

Authors:  D T Burke; G F Carle; M V Olson
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

3.  Clinical and chromosomal studies of the 18q- syndrome.

Authors:  W Wertelecki; P S Gerald
Journal:  J Pediatr       Date:  1971-01       Impact factor: 4.406

4.  IgA deficiency associated with partial deletion of chromosome 18.

Authors:  M Feingold; R S Schwartz; L Atkins; R Anderson; C S Bartsocas; D L Page; J W Littlefield
Journal:  Am J Dis Child       Date:  1969-02

5.  Distal 18q deletion without clinical findings of 18q- syndrome.

Authors:  Q H Qazi; C Madahar; S Alvi; B McGann
Journal:  Ann Genet       Date:  1980

6.  Pernicious anemia, 18q deletion syndrome, and IgA deficiency.

Authors:  R B Stricker; C A Linker
Journal:  JAMA       Date:  1982-09-17       Impact factor: 56.272

7.  Shiverer: an autosomal recessive mutant mouse with myelin deficiency.

Authors:  G F Chernoff
Journal:  J Hered       Date:  1981 Mar-Apr       Impact factor: 2.645

8.  Kinetics of transport and phosphorylation of 2-fluoro-2-deoxy-D-glucose in rat brain.

Authors:  P D Crane; W M Pardridge; L D Braun; W H Oldendorf
Journal:  J Neurochem       Date:  1983-01       Impact factor: 5.372

9.  Selective IgA deficiency with 18q+ and 18q-- karyotypic anomalies.

Authors:  R M Lewkonia; C C Lin; R H Haslam
Journal:  J Med Genet       Date:  1980-12       Impact factor: 6.318

10.  Syndromes associated with deletion of the long arm of chromosome 18[del(18q)].

Authors:  M G Wilson; J W Towner; I Forsman; E Siris
Journal:  Am J Med Genet       Date:  1979
View more
  9 in total

Review 1.  Telomeres: a diagnosis at the end of the chromosomes.

Authors:  B B A De Vries; R Winter; A Schinzel; C van Ravenswaaij-Arts
Journal:  J Med Genet       Date:  2003-06       Impact factor: 6.318

2.  Sall3 is required for the terminal maturation of olfactory glomerular interneurons.

Authors:  Susan J Harrison; Mark Parrish; A Paula Monaghan
Journal:  J Comp Neurol       Date:  2008-04-10       Impact factor: 3.215

3.  Screening for submicroscopic chromosome rearrangements in children with idiopathic mental retardation using microsatellite markers for the chromosome telomeres.

Authors:  A Slavotinek; M Rosenberg; S Knight; L Gaunt; W Fergusson; C Killoran; J Clayton-Smith; H Kingston; R H Campbell; J Flint; D Donnai; L Biesecker
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

Review 4.  Herpesviruses and chromosomal integration.

Authors:  Guillaume Morissette; Louis Flamand
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

Review 5.  Directly transmitted unbalanced chromosome abnormalities and euchromatic variants.

Authors:  J C K Barber
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

6.  Definition of a critical region on chromosome 18 for congenital aural atresia by arrayCGH.

Authors:  Joris A Veltman; Yvonne Jonkers; Inge Nuijten; Irene Janssen; Walter van der Vliet; Erik Huys; Joris Vermeesch; Griet Van Buggenhout; Jean-Pierre Fryns; Ronald Admiraal; Paulien Terhal; Didier Lacombe; Ad Geurts van Kessel; Dominique Smeets; Eric F P M Schoenmakers; Conny M van Ravenswaaij-Arts
Journal:  Am J Hum Genet       Date:  2003-05-09       Impact factor: 11.025

7.  Loss of the Sall3 gene leads to palate deficiency, abnormalities in cranial nerves, and perinatal lethality.

Authors:  M Parrish; T Ott; C Lance-Jones; G Schuetz; A Schwaeger-Nickolenko; A P Monaghan
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

8.  Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer.

Authors:  Kiyoshi Misawa; Daiki Mochizuki; Atsushi Imai; Yuki Misawa; Shiori Endo; Masato Mima; Hideya Kawasaki; Thomas E Carey; Takeharu Kanazawa
Journal:  Clin Epigenetics       Date:  2017-06-12       Impact factor: 6.551

9.  Detection of cytogenomic abnormalities by OncoScan microarray assay for products of conception from formalin-fixed paraffin-embedded and fresh fetal tissues.

Authors:  Jiadi Wen; Brittany Grommisch; Autumn DiAdamo; Hongyan Chai; Sok Meng Evelyn Ng; Pei Hui; Allen Bale; Winifred Mak; Guilin Wang; Peining Li
Journal:  Mol Cytogenet       Date:  2021-04-02       Impact factor: 2.009

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.